Your Content Goes Here Drug Delivery Systems Jimi Sta. Maria is incubating GeneHarmonics Inc. to complete the ABC of converging technologies that will usher in major innovations for the future. A stands for the ATOM which is represented by the Quantum Dot technology being used for its diagnostics devices, B stands [...]
Your Content Goes Here NanoHarmonics Asia is Gaining Speed NanoHarmonics Asia, Inc., headquartered in Rockwell Center, one of the most prestigious financial districts in Manila in the Philippines, is aggressively building the supply chain, distribution, research and development, and other strategic partnerships in that part of the world. Headed by its [...]
Your Content Goes Here Companion Data Platform and Infrastructure Jimi Sta. Maria is incubating a companion data company for the Quantum Dot Diagnostics Devices of NanoHarmonics, Inc.. The Data company will be named BitHarmonics Inc. BitHarmonics, Inc is currently being incorporated in the State of Delaware. Jimi Sta. Maria will structure BitHarmonics [...]
Your Content Goes Here A Top Scientist Joined GeneHarmonics Project GeneHarmonics Inc., the parent company of NanoHarmonics, as one of the participants in the population study that is aimed at developing datapoints to create predictive models to help fight future pandemics and present-day infectious diseases, started collaborations with John Stark, PhD of Washington [...]
Your Content Goes Here Working to Usher in the Future Covid-19 will be with us for a long time. One obvious reason is because of the rapid ways the virus mutates. Another is the direct admittance of vaccine developers about the reduced efficacies of their own respective products over time coupled [...]
Your Content Goes Here Partnering with Academic Institutions NanoHarmonics Inc. is finalizing a partnership agreement with a major US University (name to be disclosed upon the finalization of the partnership agreement). The partnership will be centered around the following major areas of collaborations: The co-development of specific NanoHarmonics Quantitative Kits and [...]
Your Content Goes Here Working Together to Save Lives NanoHarmonics Inc. concluded its discussions with ManpowerGroup Philippines Inc. successfully. The discussions ended with ManpowerGroup Philippines Inc. issuing a formal Letter of Intent to NanoHarmonics Inc. An actual contract shall be executed between the two companies once commercial terms are finalized based [...]
Your Content Goes Here More Bioavailability, Less Side-Effects NanoHarmonics is working with several biotech companies to develop, do clinical trials, secure regulatory compliance approvals, and commercialize improved drugs. We aim to reformulate and repurpose existing medicines for oncology, for infectious diseases as well as develop new ones in partnership with [...]
Your Content Goes Here The future of bio-diagnostics Quantum dots are nanoparticles that exhibit physical properties distinct from their bulk counterparts. They fluoresce into different colors, they can be excited to emit waves, and they can be tuned based on size. In 1998, a paper was published describing how Quantum Dots [...]
Your Content Goes Here NanoHarmonics on Drug Delivery Systems NanoHarmonics Inc., in line with its strategic plan of integrating cutting-edge drug delivery system along with its QDot bio-diagnostic devices and data platform, merged with Avagen Pharma. NANOHARMONICS INC. now owns 100% of Avagen Pharma Inc. Avagen is the global licensee of [...]
© All Rights Reserved 2024
